Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 15, 2015 07:05 ET | Source: Immunovaccine Inc.

Immunovaccine to Present at American Association for Cancer Research (AACR) 2015 Annual Meeting

HALIFAX, NOVA SCOTIA--(Marketwired - April 15, 2015) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV), a clinical stage vaccine and immunotherapy company, announced today...
March 31, 2015 07:00 ET | Source: Immunovaccine Inc.

Immunovaccine to Present at World Vaccine Congress 2015

HALIFAX, NOVA SCOTIA--(Marketwired - March 31, 2015) - Immunovaccine Inc. ("Immunovaccine") (TSX:IMV), a clinical stage vaccine and immunotherapy company, today announced that its chief...
March 24, 2015 07:00 ET | Source: Immunovaccine Inc.

Immunovaccine Initiates Phase 2 Clinical Trial of DPX-Survivac Immunotherapy in Recurrent Lymphoma

HALIFAX, NOVA SCOTIA--(Marketwired - March 24, 2015) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX:IMV), a clinical stage vaccine and immunotherapy company, today announced that it...
March 20, 2015 16:30 ET | Source: Immunovaccine Inc.

Immunovaccine Announces 2014 Year-End Results

HALIFAX, NOVA SCOTIA--(Marketwired - March 20, 2015) - Immunovaccine Inc. (TSX:IMV), a clinical stage vaccine company, today announced its financial and operational results for the year...
March 16, 2015 07:00 ET | Source: Immunovaccine Inc.

Immunovaccine Announces Intent to Trade on OTCQX Marketplace in United States

HALIFAX, NOVA SCOTIA--(Marketwired - March 16, 2015) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX:IMV), a clinical stage vaccine and immunotherapy company, today announced that it...
February 27, 2015 12:37 ET | Source: Immunovaccine Inc.

Immunovaccine Disclaims Hoax Press Release

HALIFAX, NOVA SCOTIA--(Marketwired - Feb. 27, 2015) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV) has been made aware of a fraudulent press release disseminated this...
February 03, 2015 07:00 ET | Source: Immunovaccine Inc.

Immunovaccine to Present at 17th Annual BIO CEO & Investor Conference

HALIFAX, NOVA SCOTIA--(Marketwired - Feb. 3, 2015) - Immunovaccine Inc. ("Immunovaccine") (TSX:IMV), a clinical stage vaccine and immunotherapy company, today announced that its chief...
January 28, 2015 07:00 ET | Source: Immunovaccine Inc.

Immunovaccine Study Demonstrates Early Protection Against Anthrax with Single Dose Experimental Vaccines

HALIFAX, NOVA SCOTIA--(Marketwired - Jan. 28, 2015) - Immunovaccine Inc. ("Immunovaccine") (TSX:IMV), a clinical stage vaccine and immunotherapy company, today announced that three...
January 20, 2015 07:00 ET | Source: Immunovaccine Inc.

Health Canada Clears Immunovaccine to Conduct Phase I Clinical Trial of Respiratory Syncytial Virus (RSV) Vaccine

HALIFAX, NOVA SCOTIA--(Marketwired - Jan. 20, 2015) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX:IMV), a clinical stage vaccine and immunotherapy company, today announced that it...
January 07, 2015 07:00 ET | Source: Immunovaccine Inc.

Immunovaccine to Present at 7th Annual Biotech Showcase Conference

HALIFAX, NOVA SCOTIA--(Marketwired - Jan. 7, 2015) - Immunovaccine Inc. ("Immunovaccine") (TSX:IMV), a clinical stage vaccine and immunotherapy company, today announced that its chief...